Brief: Y-mAbs Reports Q3 2024 Financial Results And Recent Corporate Developments

Y-mAbs Therapeutics

08/11/2024 11:37

Nov 8 (Reuters) - Y-mAbs Therapeutics Inc  YMAB.O :
    * Y-MABS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND
RECENT
CORPORATE DEVELOPMENTS
    * Y-MABS THERAPEUTICS - REITERATES FULL YEAR 2024 GUIDANCE
    * Y-MABS THERAPEUTICS INC: QTRLY TOTAL NET REVENUE $18.5
MILLION
    * Y-MABS THERAPEUTICS INC: QTRLY NET LOSS PER SHARE $0.16

Source text:  ID:nGNX4qDFPW 
Further company coverage:  YMAB.O 

 ((Reuters.Briefs@thomsonreuters.com;))